1
|
Wang Q, Bai L, Luo S, Wang T, Yang F, Xia J, Wang H, Ma K, Liu M, Wu S, Wang H, Guo S, Sun X, Xiao Q. TMEM16A Ca 2+-activated Cl - channel inhibition ameliorates acute pancreatitis via the IP 3R/Ca 2+/NFκB/IL-6 signaling pathway. J Adv Res 2020; 23:25-35. [PMID: 32071789 PMCID: PMC7016042 DOI: 10.1016/j.jare.2020.01.006] [Citation(s) in RCA: 33] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2019] [Revised: 01/14/2020] [Accepted: 01/18/2020] [Indexed: 02/08/2023] Open
Abstract
TMEM16A Ca2+-activated Cl- channels are expressed in pancreatic acinar cells and participate in inflammation-associated diseases. Whether TMEM16A contributes to the pathogenesis of acute pancreatitis (AP) remains unknown. Here, we found that increased TMEM16A expression in the pancreatic tissue was correlated with the interleukin-6 (IL-6) level in the pancreatic tissue and in the serum of a cerulein-induced AP mouse model. IL-6 treatment promoted TMEM16A expression in AR42J pancreatic acinar cells via the IL-6 receptor (IL-6R)/signal transducers and activators of transcription 3 (STAT3) signaling pathway. In addition, TMEM16A was co-immunoprecipitated with the inositol 1,4,5-trisphosphate receptor (IP3R) and was activated by IP3R-mediated Ca2+ release. TMEM16A inhibition reduced the IP3R-mediated Ca2+ release induced by cerulein. Furthermore, TMEM16A overexpression activated nuclear factor-κB (NFκB) and increased IL-6 release by increasing intracellular Ca2+. TMEM16A knockdown by shRNAs reduced the cerulein-induced NFκB activation by Ca2+. TMEM16A inhibitors inhibited NFκB activation by decreasing channel activity and reducing TMEM16A protein levels in AR42J cells, and it ameliorated pancreatic damage in cerulein-induced AP mice. This study identifies a novel mechanism underlying the pathogenesis of AP by which IL-6 promotes TMEM16A expression via IL-6R/STAT3 signaling activation, and TMEM16A overexpression increases IL-6 secretion via IP3R/Ca2+/NFκB signaling activation in pancreatic acinar cells. TMEM16A inhibition may be a new potential strategy for treating AP.
Collapse
Key Words
- AP, acute pancreatitis
- Acute pancreatitis
- BAPTA-AM, 1,2-bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid-acetyloxymethyl ester
- CCK, cholesystokinin
- CFBE, cystic fibrosis bronchial epithelial
- CaCCinh-A01, Ca2+-activated Cl− channel inhibitor-A01
- EDTA, ethylenediaminetetraacetic acid
- EGF, epidermal growth factor
- EGFP, green fluorescent protein
- EGFR, epidermal growth factor receptor
- EGTA, ethylene glycol-bis(2-aminoethyl ether)-N,N,N',N'-tetraacetic acid
- ELISA, enzyme-linked immunosorbent assay
- ER, endoplasmic reticulum
- FBS, fetal bovine serum
- HEPES, N-2-hydroxyethil-piperazine-N'-2-ethanesulfonic acid
- IL-6, interleukin 6
- IL-6R, interleukin 6 receptor
- IP3R, inositol 1,4,5-trisphosphate receptor
- Inositol 1,4,5-trisphosphate receptor
- Interleukin-6
- NFκB
- NFκB, nuclear factor-κB
- NMDG, N-methyl-D-glucamine
- NP-40, Nonidet P-40
- PACs, pancreatic acinar cells
- RIPA, radio immunoprecipitation assay
- SDS-PAGE, sodium dodecyl sulfate polyacrylamide gel electrophoresis
- STAT3, signal transducers and activators of transcription 3
- T16Ainh-A01, TMEM16A inhibitor-A01
- TMEM16A
- Tris, tris(hydroxymethyl)aminomethane
- WT, wild type
- shRNAs, short hairpin RNAs
Collapse
Affiliation(s)
- Qinghua Wang
- Department of Ion Channel Pharmacology, School of Pharmacy, China Medical University, Shenyang 110122, China.,Department of Experimental Center, The Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang 110032, China
| | - Lichuan Bai
- Department of Ion Channel Pharmacology, School of Pharmacy, China Medical University, Shenyang 110122, China
| | - Shuya Luo
- Department of Ion Channel Pharmacology, School of Pharmacy, China Medical University, Shenyang 110122, China
| | - Tianyu Wang
- Department of Ion Channel Pharmacology, School of Pharmacy, China Medical University, Shenyang 110122, China
| | - Fan Yang
- Department of Ion Channel Pharmacology, School of Pharmacy, China Medical University, Shenyang 110122, China
| | - Jialin Xia
- Department of Ion Channel Pharmacology, School of Pharmacy, China Medical University, Shenyang 110122, China
| | - Hui Wang
- Department of Ion Channel Pharmacology, School of Pharmacy, China Medical University, Shenyang 110122, China
| | - Ke Ma
- Department of Ion Channel Pharmacology, School of Pharmacy, China Medical University, Shenyang 110122, China
| | - Mei Liu
- Department of Ion Channel Pharmacology, School of Pharmacy, China Medical University, Shenyang 110122, China
| | - Shuwei Wu
- Department of Ion Channel Pharmacology, School of Pharmacy, China Medical University, Shenyang 110122, China
| | - Huijie Wang
- Department of Ion Channel Pharmacology, School of Pharmacy, China Medical University, Shenyang 110122, China
| | - Shibin Guo
- Department of Gastroenterological Endoscopy, the First Affiliated Hospital of Dalian Medical University, Dalian 116011, China
| | - Xiaohong Sun
- Department of Neurology, The Fourth Affiliated Hospital of China Medical University, Shenyang 110032, China
| | - Qinghuan Xiao
- Department of Ion Channel Pharmacology, School of Pharmacy, China Medical University, Shenyang 110122, China
| |
Collapse
|